ATE61057T1 - Carbapeneme die einen externen alkylierten 2quatern|ren pyridiniumalkylthio-substituenten besitzen. - Google Patents

Carbapeneme die einen externen alkylierten 2quatern|ren pyridiniumalkylthio-substituenten besitzen.

Info

Publication number
ATE61057T1
ATE61057T1 AT85108135T AT85108135T ATE61057T1 AT E61057 T1 ATE61057 T1 AT E61057T1 AT 85108135 T AT85108135 T AT 85108135T AT 85108135 T AT85108135 T AT 85108135T AT E61057 T1 ATE61057 T1 AT E61057T1
Authority
AT
Austria
Prior art keywords
carbapenems
2quaternal
pyridinium
alkylated
possessing
Prior art date
Application number
AT85108135T
Other languages
English (en)
Inventor
Burton G Christensen
Susan M Schmitt
David B R Johnston
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE61057T1 publication Critical patent/ATE61057T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
AT85108135T 1984-07-02 1985-07-01 Carbapeneme die einen externen alkylierten 2quatern|ren pyridiniumalkylthio-substituenten besitzen. ATE61057T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62657984A 1984-07-02 1984-07-02
EP85108135A EP0167139B1 (de) 1984-07-02 1985-07-01 Carbapeneme die einen externen alkylierten 2-quaternären Pyridiniumalkylthio-Substituenten besitzen

Publications (1)

Publication Number Publication Date
ATE61057T1 true ATE61057T1 (de) 1991-03-15

Family

ID=24510989

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85108135T ATE61057T1 (de) 1984-07-02 1985-07-01 Carbapeneme die einen externen alkylierten 2quatern|ren pyridiniumalkylthio-substituenten besitzen.

Country Status (7)

Country Link
EP (1) EP0167139B1 (de)
JP (1) JPS6163678A (de)
AT (1) ATE61057T1 (de)
CA (1) CA1273011A (de)
DE (1) DE3581847D1 (de)
DK (1) DK297385A (de)
ES (1) ES8609337A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339860C (en) * 1985-06-17 1998-05-12 Tsunehiko Soga Derivatives of penem
US4880922A (en) * 1985-11-22 1989-11-14 Bristol-Myers Company Carbapenems with quaternized heterothioalkylthio substitution at position 2
NZ219892A (en) * 1986-04-15 1991-02-26 Merck & Co Inc N-amino quaternised heteroarylium carbapenem derivatives and pharmaceutical compositions thereof
JP2752143B2 (ja) * 1988-04-01 1998-05-18 三共株式会社 カルバペネム誘導体
US5242914A (en) * 1988-04-01 1993-09-07 Sankyo Company, Limited 2-(heterocyclylthio) carbapenem derivatives, their preparation and their use as antibiotics
ATE114654T1 (de) * 1988-04-01 1994-12-15 Sankyo Co 2-(heterocyclylthio)carbapenemderivate, deren herstellung und deren verwendung als antibiotika.
WO1991000864A1 (en) * 1989-07-07 1991-01-24 Banyu Pharmaceutical Co., Ltd. Carbapenem derivatives
US5116833A (en) * 1990-10-19 1992-05-26 Bristol-Myers Squibb Company Antibiotic c-3 dithioacetal-substituted carbapenem compounds, compositions, and methods of use thereof
US5496816A (en) * 1994-03-14 1996-03-05 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
FI119756B (fi) * 1995-01-18 2009-03-13 Alteon Inc Tiatsoliumyhdisteiden käyttö pitkälle edenneen glykosylaation lopputuotteiden muodostumisen estossa ja suunnan muutoksessa
US5656261A (en) 1995-01-18 1997-08-12 The Picower Institute For Medical Research Preventing and reversing advanced glycosylation endproducts
WO1996022095A2 (en) * 1995-01-18 1996-07-25 Alteon Inc. Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts
DE19840943A1 (de) * 1998-09-08 2000-03-09 Aventis Res & Tech Gmbh & Co Verfahren zur Herstellung von Derivaten des 4-Alkylsulfinylmethylarylenmethanols
US6121300A (en) * 1998-11-10 2000-09-19 Wagle; Dilip R. Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
US20050014747A1 (en) 2003-04-18 2005-01-20 Emily Reinhard Dihydrothiazine prodrugs of thiazolium agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR244550A1 (es) * 1978-07-24 1993-11-30 Merck & Co Inc Procedimiento para obtener una composicion de antibioticos del tipo de la tienamicina con inhibidores de la dipeptidasa
US4376774A (en) * 1979-05-29 1983-03-15 Merck & Co., Inc. Antibiotic N-heterocyclyl thienamycin
NZ201471A (en) * 1981-08-10 1985-09-13 Merck & Co Inc Antibacterial compositions containing penems and dipeptidase inhibitors
CA1269978A (en) * 1982-09-28 1990-06-05 Choung U. Kim Carbapenem antibiotics
ZA836966B (en) * 1982-09-28 1984-04-25 Bristol Myers Co Carbapenem antibiotics

Also Published As

Publication number Publication date
ES8609337A1 (es) 1986-09-01
DK297385A (da) 1986-03-14
EP0167139B1 (de) 1991-02-27
DK297385D0 (da) 1985-07-01
DE3581847D1 (de) 1991-04-04
ES544752A0 (es) 1986-09-01
CA1273011A (en) 1990-08-21
JPS6163678A (ja) 1986-04-01
EP0167139A1 (de) 1986-01-08

Similar Documents

Publication Publication Date Title
ATE61057T1 (de) Carbapeneme die einen externen alkylierten 2quatern|ren pyridiniumalkylthio-substituenten besitzen.
BR8700200A (pt) Conjunto fechador de porta
DE3860818D1 (de) Drehtuer.
IN170909B (de)
ES8609336A1 (es) Un procedimiento para la preparacion de -1-metilcarbapenems.
DE3684207D1 (de) Blindleistungskompensator.
AU5416886A (en) Antibacterial compounds, their production and use
DE3777026D1 (de) Blindleistungskompensator.
AU6307586A (en) Quinoline derivatives
DE3860977D1 (en) (1r,5s,6s)-2-(substituiertes thio)-6-((r)-1-hydroxy-aethyl)-1-methyl-carbapenem-3-carbonsaeurederivate.
FI915194A0 (fi) Heteroaroylderivat av monocykliska b-laktamantibiotika.
NL192256B (nl) Verzonken schuifraamsamenstel.
DK297485A (da) Carbapenemer med kvaternaere heteroarylalkylthio 2-substituenter samt laegemiddel indeholdende saadanne forbindelser
IE823087L (en) Azetidinones.
DE3863241D1 (de) Mechanischer tuerschliesser.
NO862209D0 (no) Energiutvinning.
ATE54151T1 (de) Erythromycylamin-derivate.
NO875125L (no) Elastisk pakning for doerer, vinduer o.l.
DE3779856D1 (de) Antibakterielle, 2-substituierte alkyl-carbapeneme.
PT85645A (en) 2-(1-oxo-1-imino-1-thiacylcloalkyl)-thiopenem derivatives
JPS57158754A (en) Improvement on organic compounds
FI870286A0 (fi) Anordning foer aostadkommande av dubbelriktad kommunikation i underjordiska utrymmen.
FR2594474B1 (fr) Ferme-porte hydraulique
IT8522563V0 (it) Coppia di profili cooperanti, atta a consentire una corretta chiusura delle ante scorrevoli di armadi.
SU1374724A1 (ru) 1-фосфонометил-2-иминоимидазолидин-4-он, обладающий гербицидной активностью

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee